Hitt Sharma

Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9–14 years versus an established quadrivalent HPV vaccine in women aged 15–26 years in India: a randomised, active-controlled, multicentre, phase 2/3 trial

Hitt Sharma, Sameer Parekh, Pramod Pujari et al. · The Lancet Oncology · 2023 · 35 citations

Vaccination, Vaccine Safety, Vaccinology +12

Results of the phase I open label clinical trial SAKK 06/14 assessing safety of intravesical instillation of VPM1002BC, a recombinant mycobacterium Bacillus Calmette Guérin (BCG), in patients with non-muscle invasive bladder cancer and previous failure of conventional BCG therapy

Cyrill A. Rentsch, Piet Bosshard, G. Mayor et al. · OncoImmunology · 2020 · 31 citations · Full text

VPM1002 as Prophylaxis Against Severe Respiratory Tract Infections Including Coronavirus Disease 2019 in the Elderly: A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Study

Alexandra M Blossey, Sina Brückner, Marcus May et al. · Clinical Infectious Diseases · 2022 · 31 citations · Full text

Seroprevalence of rubella and immunogenicity following rubella vaccination in adolescent girls in India

Hitt Sharma, V S Padbidri, Subhash V. Kapre et al. · The Journal of Infection in Developing Countries · 2011 · 30 citations · Full text

Immunogenicity and safety of an indigenously manufactured reconstituted pentavalent (DTwP-HBV+Hib) vaccine in comparison with a foreign competitor following primary and booster immunization in Indian children

Hitt Sharma, Sangita Yadav, Sanjay Lalwani et al. · Human Vaccines · 2011 · 29 citations